Our case showed that HE may present with sensorimotorpolyneuropathy; therefore HE should be considered in the differential diagnosesof polyneuropathy.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Hashimoto’s encephalopathy (HE) is a rare, auto-immune disease characterizedby symptoms of acute or subacute encephalopathy associated with increasedanti-thyroid antibody levels.
📊
Key Findings & Data:The course of most HE cases is relapsing andremitting, which is similar to that of vasculitis and stroke.
💡
Conclusion & Impact:Our case showed that HE may present with sensorimotorpolyneuropathy; therefore HE should be considered in the differential diagnosesof polyneuropathy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Hashimoto’s encephalopathy (HE) is a rare, auto-immune disease characterizedby symptoms of acute or subacute encephalopathy associated with increasedanti-thyroid antibody levels. The course of most HE cases is relapsing andremitting, which is similar to that of vasculitis and stroke. Steroids are thefirst line treatment in HE. In steroid non-responders other immunomodulatorytherapies or plasmapheresis could be applied. We report a case of steroidresistance HE with sensorimotor polyneuropathy, as a rare presentation ofthis disorder. Our case showed that HE may present with sensorimotorpolyneuropathy; therefore HE should be considered in the differential diagnosesof polyneuropathy.
🔖
Cite This Article
EMEKSİZ, S., KUTLU, N. O., ALAÇAKIR, N., ÇAKSEN, H. (2018). A case of steroid-resistance Hashimoto's encephalopathy presenting with sensorimotor polyneuropathy. Turkish Journal of Pediatrics, Cilt: 60 - Sayı: 3, 310–314. https://ajindex.com/articles/412182
Yu HJ, Lee J, Seo DW, Lee M. Clinical manifestations and treatment response of steroid in pediatric Hashimoto encephalopathy. J Child Neurol 2014; 29: 938-942
Wang J, Zhang J, Xu L, Shi Y, Wu X, Guo Q. Cognitive impairments in Hashimoto’s encephalopathy: A casecontrol study. PLoS One 2013; 8: e55758
Ghoreishi E, Shahidi GA, Rohani M, Nabavi M, Aghaei M, Akhoundi FH. Palatal-Myoclonus as a presentation of Hashimoto Encephalopathy: An interesting case report. Iran J Psychiatry 2013; 8: 149-151
Huang X, Yu Y, Zhang H, et al. Hashimoto encephalopathy associated with hyperthyroidism: A case report. Exp Ther Med 2014; 8: 515-518
Tang Y, Xing Y, Lin MT, Zhang J, Jia J. Hashimoto’s encephalopathy cases: Chinese experience. BMC Neurol 2012; 12: 60
Santra G, De D, Phaujdar S, Rudra A, Dutta PS. Hashimoto's encephalopathy. J Assoc Physicians India 2012; 60: 48-51
Singh H, Ray S, Agarwal S, Verma RP, Talapatra P, Gupta V. Spectroscopic correlation and role of Azathioprine in long-term remission in patients of Hashimoto encephalopathy. Ann Indian Acad Neurol 2013; 16: 443-446
Sheng B, Lau KK, Li HL, Cheng LF. A case of Hashimoto's encephalopathy with demyelinating peripheral neuropathy. Eur Neurol 2005; 53: 84-85
Bairactaris C, Stouraitis G, Papalias E, Fakas N, Papatheodorou G, Gourtzelidis P. Early neurophysiological evolution of chronic inflammatory demyelinating polyneuropathy in a patient with Hashimoto's thyroiditis. Muscle Nerve 2008; 38: 1518- 1522
Salpietro V, Mankad K, Polizzi A, et al. Pediatric Hashimoto's encephalopathy w